DE3588205T2 - Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten - Google Patents

Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten

Info

Publication number
DE3588205T2
DE3588205T2 DE3588205T DE3588205T DE3588205T2 DE 3588205 T2 DE3588205 T2 DE 3588205T2 DE 3588205 T DE3588205 T DE 3588205T DE 3588205 T DE3588205 T DE 3588205T DE 3588205 T2 DE3588205 T2 DE 3588205T2
Authority
DE
Germany
Prior art keywords
adenosine
intravenous infusion
continuous intravenous
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3588205T
Other languages
English (en)
Other versions
DE3588205D1 (de
Inventor
Alf Sollevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Item Development AB
Original Assignee
Item Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3588205(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Item Development AB filed Critical Item Development AB
Publication of DE3588205D1 publication Critical patent/DE3588205D1/de
Application granted granted Critical
Publication of DE3588205T2 publication Critical patent/DE3588205T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
DE3588205T 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten Expired - Lifetime DE3588205T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (2)

Publication Number Publication Date
DE3588205D1 DE3588205D1 (de) 1999-03-11
DE3588205T2 true DE3588205T2 (de) 1999-06-02

Family

ID=25116698

Family Applications (4)

Application Number Title Priority Date Filing Date
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten

Country Status (9)

Country Link
EP (2) EP0275249B2 (de)
JP (1) JP2535504B2 (de)
AT (2) ATE176154T1 (de)
AU (1) AU613304B2 (de)
CA (1) CA1301652C (de)
DE (4) DE3590855T1 (de)
DK (1) DK253187A (de)
NZ (1) NZ217592A (de)
WO (1) WO1987001593A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618723B2 (en) * 1986-10-06 1992-01-09 University Of Virginia Alumni Patents Foundation, The Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US20130288370A1 (en) 2010-10-15 2013-10-31 Cytopherx, Inc. Cytopheresis cartridges and use thereof
CA2852220A1 (en) 2011-10-14 2013-07-18 Cytopherx, Inc. Cartridge and method for increasing myocardial function
JP5729660B2 (ja) * 2011-11-21 2015-06-03 株式会社ディナーヴ 腎動脈アブレーション用のカテーテルおよびシステム

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7464B (en) * 1973-01-16 1974-11-27 J Voorhees Treatment of proliferating skin diseases with papavine alkaloids
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
EP0275249B1 (de) 1993-01-13
CA1301652C (en) 1992-05-26
DE19975044I2 (de) 2006-02-02
DE3586993D1 (de) 1993-02-25
EP0275249A1 (de) 1988-07-27
JPS63501497A (ja) 1988-06-09
DE3586993T3 (de) 1998-03-19
ATE176154T1 (de) 1999-02-15
DE3586993T2 (de) 1993-04-29
DE3590855T1 (de) 1988-08-25
EP0506205B1 (de) 1999-01-27
AU613304B2 (en) 1991-08-01
DE3588205D1 (de) 1999-03-11
DK253187D0 (da) 1987-05-19
JP2535504B2 (ja) 1996-09-18
EP0506205A1 (de) 1992-09-30
WO1987001593A1 (en) 1987-03-26
DK253187A (da) 1987-05-19
NZ217592A (en) 1990-10-26
AU5065585A (en) 1987-04-07
EP0275249B2 (de) 1997-12-17
ATE84419T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
Bourgeois et al. Characteristics of aortic diastolic pressure decay with application to the continuous monitoring of changes in peripheral vascular resistance
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
ATE485863T1 (de) Implantierbares system
DE3662968D1 (en) Coronary perfusion pump
EP0904012A4 (de) Vorrichtung und verfahren zur blutstrom-messungmittels analyse der biologischen impedanz
KR900701308A (ko) 감마-인터페론을 이용한 혈관 협착증의 치료방법
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
DE3588205D1 (de) Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
Hager et al. Hypertension self-control with a portable feedback unit or meditation-relaxation
Neill et al. Acute and chronic cardiovascular adjustments to induced anemia in dogs
Willis III THE HEMODYNAMIC EFFECTS OF NORPACE (Part II).
Thomas et al. Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
Davis et al. Comparison of changes in blood volume and opacity in dog digital pad and tongue.
Abrahams Intramuscular heparin
Kimball Non-cooperation: An examination of factors leading to non-compliance in a hypertension clinic.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
Herles et al. Regional reactivity of the lung vessels to minute changes of acidity of perfusing fluid
Slósarska et al. Physiological reactivity of patients with endogenous and neurotic depression.
Dennis Pressure measurements in the lesser circulation of the newborn rabbit
Lochner Present Basis of Coronary Therapy
HEWLETT The action of tyramin on the circulation of man
Sadick et al. Hyperemic response to coronary occlusion during a single diastole in conscious dog
Bushman Instrumentation and control in intensive care
Asnes Depression in a patient facing heart surgery: Past history and treatment.

Legal Events

Date Code Title Description
V448 Application of spc

Free format text: PRODUCT NAME: ADENOSIN; REGISTRATION NO/DATE: 40307.00.00, 19970721

Spc suppl protection certif: 199 75 044

Filing date: 19990629

V457 Spc granted

Free format text: PRODUCT NAME: ADENOSIN; REGISTRATION NO/DATE: 40307.00.00, 19970721

Spc suppl protection certif: 199 75 044

Filing date: 19990629

V484 Delivery of the decision of grant

Free format text: PRODUCT NAME: ADENOSIN; REGISTRATION NO/DATE: 40307.00.00, 19970721

Spc suppl protection certif: 199 75 044

Filing date: 19990629

V464 Spc expired

Free format text: PRODUCT NAME: ADENOSIN; REGISTRATION NO/DATE: 40307.00.00, 19970721

Spc suppl protection certif: 199 75 044

Filing date: 19990629